Jeppe Øvlesen
Fondatore presso SYNACT PHARMA AB
Posizioni attive di Jeppe Øvlesen
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| SYNACT PHARMA AB | Direttore/Membro del Consiglio | 20/03/2024 | - |
| Amministratore Delegato | 20/03/2024 | - | |
| Fondatore | - | - | |
| CERENO SCIENTIFIC AB | Direttore/Membro del Consiglio | - | - |
Cercare Medical A/S
 Cercare Medical A/S Packaged SoftwareTechnology Services Cercare Medical ApS provides automated identification of viable tissue in acute stroke. It develops technology within medical image processing and image database analytics. The firm creates diagnostic software. The company was founded by Kim Mouridsen and Mikkel Bo Hansen in October 2013 and is headquartered in Aarhus, Denmark. | Presidente | - | - |
Go-PEN Aps
 Go-PEN Aps Medical SpecialtiesHealth Technology Go-Pen ApS develops insulin pen. The Danish company was founded in 2019 by Ole Kjerkegaard Nielsen, Michael Ejstrup Hansen. Ole Kjerkegaard Nielsen has been the CEO since 2019. | Presidente | - | - |
Neurescue ApS
 Neurescue ApS Medical SpecialtiesHealth Technology Neurescue ApS develops innovative medical devices for the treatment of cardiac arrest. It offers new platform of treatment methods for paramedics, nurses and doctors alike. The company was founded by Habib Frost in 2013 and is headquartered in Copenhagen, Denmark. | Presidente | 01/03/2020 | - |
| Perfusion Tech ApS | Direttore/Membro del Consiglio | 25/10/2017 | - |
| Corporate Culture ApS | Corporate Officer/Principal | 30/06/2014 | - |
| Quantass ApS | Corporate Officer/Principal | 08/05/2013 | - |
| Direttore/Membro del Consiglio | 01/01/2011 | 08/05/2013 | |
ResoTher Pharma AS
 ResoTher Pharma AS Pharmaceuticals: MajorHealth Technology ResoTher Pharma is a privately held clinical-stage biotech company based in Copenhagen, Denmark. ResoTher Pharma focuses on developing compounds that induce inflammatory resolution in cardiovascular diseases. The Danish company's lead compound, RTP-026, has shown to have a profound effect on reducing infarction size and restoring cardiac function to a pre-infarction level. ResoTher Pharma's mission is to create novel medicines that benefit patients in need by addressing unmet needs in CVD inflammation through endogenous immune regulatory pathways. The company was founded in 2016 by Thomas Jonassen and is privately owned by a group of prominent Danish investors. | Direttore/Membro del Consiglio | 11/07/2018 | - |
| Presidente | 04/07/2016 | 11/07/2018 | |
| ░░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
| ░░░░░░░░░░ ░░░ | ░░░░░░░░ | ░░░░░░░░░░ | - |
| ░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
Storia della carriera di Jeppe Øvlesen
Precedenti posizioni note di Jeppe Øvlesen
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| ░░░░░░ ░░░░░░ ░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
| ░░░░░░ ░░░░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
| ░░░░░░░ ░░░░░░░ ░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
| ░░░░░░░ ░░ ░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
| ░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
| ░░░░░░░ ░░░░░ ░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░░ ░░░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░ ░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
| ░░░░░░ ░░░░░░ ░░░ | ░░░░░░░░ ░░ ░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░ ░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░ ░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
| ░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
| ░░░ ░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | - | - |
| ░░░░░░░░ | - | - | |
| ░░░░░░░ | - | - | |
| ░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
| ░░░░░░░░░░░ ░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - | |
| ░░░ ░░░░░░░ ░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | - | - |
| ░░░ ░░░░░░░ ░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | - | - |
| ░░░░░░░ | - | - | |
| ░░░░░░ ░░░░░░ ░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
| ░░░░░░░ | - | - |
Formazione di Jeppe Øvlesen
| University of Hartford | Masters Business Admin |
Statistiche
Distribuzione geografica
| Danimarca | 23 |
| Svezia | 3 |
| Stati Uniti | 2 |
Posizioni
| Director/Board Member | 15 |
| Chief Executive Officer | 8 |
| Chairman | 7 |
Settori
| Health Technology | 8 |
| Technology Services | 6 |
| Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 4 |
|---|---|
| CHEMOMETEC A/S | Health Technology |
| SYNACT PHARMA AB | Health Technology |
| CERENO SCIENTIFIC AB | Health Technology |
| MONSENSO A/S | Technology Services |
| Aziende private | 22 |
|---|---|
Action Pharma A/S
 Action Pharma A/S BiotechnologyHealth Technology Action Pharma A/S is an R&D-focused biotech company located in the Nordic Medicon Valley area in Copenhagen, Denmark. Action Pharma was founded in 2000 and has a pipeline of 4 drug candidates in different stages of development, plus additional compounds in discovery and early preclinical development. Action Pharma pursues the discovery and development of new drugs and treatment concepts to treat cardiovascular diseases, inflammatory diseases and metabolic diseases, such as type-II diabetes and obesity. Its drug candidates are modified endogenous peptides with improved efficacy and small chemical entities targeted the melanocortin receptors. In disease models, its drug candidates have shown strong effects in treating and preventing inflammation and organ damage in conditions such as post-surgical organ dysfunction and acute myocardial infarction. A major focus for Action Pharma is treatment candidates for type-II diabetes, obesity and metabolic syndrome. Moreover, several drug candidates have shown effects in treating inflammatory diseases, such as rheumatoid arthritis, inflammatory bowel disease, multiple sclerosis and dermatitis. | Health Technology |
QIAGEN Aarhus A/S
 QIAGEN Aarhus A/S Packaged SoftwareTechnology Services QIAGEN Aarhus A/S develops and markets software and hardware solutions and consultancy services within bioinformatics. Its products include workbench, server solutions, database, and modules. The company was founded by Thomas Knudsen and Bjarne Knudsen in 2004 and is headquartered in Aarhus, Denmark. | Technology Services |
Getinge Cetrea A/S
 Getinge Cetrea A/S Packaged SoftwareTechnology Services Getinge Cetrea A/S develops clinical logistics and communication software products. Its products include insight enterprise, insight emergency, insight surgical, insight ICU and insight patient ward. The company was founded by Kakob E. Bardram in 2006 and is headquartered in Aarhus Nord, Denmark. | Technology Services |
NordEnergie Renewables A/S
 NordEnergie Renewables A/S Electric UtilitiesUtilities NordEnergie Renewables A/S is a holding company that supplies households with pure and renewable energy. It is an independent power producer of wind power, an alternative to the traditional ways of generating energy. The firm owns and operates wind parks situated in Germany and Sweden. The company was founded in November 2007 and is headquartered in Copenhagen, Denmark. | Utilities |
| PNN Medical A/S | |
| Vingmed Danmark A/S | |
| Enovacor ApS | |
| Vikarbasen A/S | |
| PNN Medical SA | |
| Sundialog A/S | |
Cercare Medical A/S
Cercare Medical A/S Packaged SoftwareTechnology Services Cercare Medical ApS provides automated identification of viable tissue in acute stroke. It develops technology within medical image processing and image database analytics. The firm creates diagnostic software. The company was founded by Kim Mouridsen and Mikkel Bo Hansen in October 2013 and is headquartered in Aarhus, Denmark. | Technology Services |
Neurescue ApS
Neurescue ApS Medical SpecialtiesHealth Technology Neurescue ApS develops innovative medical devices for the treatment of cardiac arrest. It offers new platform of treatment methods for paramedics, nurses and doctors alike. The company was founded by Habib Frost in 2013 and is headquartered in Copenhagen, Denmark. | Health Technology |
Vintage Cloud A/S
 Vintage Cloud A/S Electronics DistributorsDistribution Services Vintage Cloud ApS engages in the wholesale of computers, peripherals, and software. The firm’s purpose is the development and sale of archive systems and related activities. The company was founded on February 21, 2012 and is headquartered in Copenhagen, Denmark. | Distribution Services |
| Corporate Culture ApS | |
ResoTher Pharma AS
ResoTher Pharma AS Pharmaceuticals: MajorHealth Technology ResoTher Pharma is a privately held clinical-stage biotech company based in Copenhagen, Denmark. ResoTher Pharma focuses on developing compounds that induce inflammatory resolution in cardiovascular diseases. The Danish company's lead compound, RTP-026, has shown to have a profound effect on reducing infarction size and restoring cardiac function to a pre-infarction level. ResoTher Pharma's mission is to create novel medicines that benefit patients in need by addressing unmet needs in CVD inflammation through endogenous immune regulatory pathways. The company was founded in 2016 by Thomas Jonassen and is privately owned by a group of prominent Danish investors. | Health Technology |
| Quantass ApS | |
Mindway AI ApS
 Mindway AI ApS Information Technology ServicesTechnology Services Mindway AI ApS operates as a software company, which engages in the development of technical solutions for gambling purposes. Its artificial intelligence system works with betting operators, platform providers, regulators, and governments to apply early detection and intervention for safer gambling and gaming activities. The company was founded by Kim Mouridsen and is headquartered in Aarhus, Denmark. | Technology Services |
CPHI-Holding A/S
 CPHI-Holding A/S Miscellaneous Commercial ServicesCommercial Services CPHI-Holding A/S is a Danish company based in Rodovre, Denmark. The CEOs are Michael Østerlund Madsen, Peter Scheuer Jensen. CPHI-Holding develops airport solutions to enhance passenger experience, including security scanner systems, intelligent trolleys, and baggage handling technologies. The private company has a team of over 30 employees. The company was founded in 1999 by Lars Hojgaard Thogersen, Søren Jakobsen, Rasmus Halfdan Breck. | Commercial Services |
ACT.Global A/S
 ACT.Global A/S Industrial MachineryProducer Manufacturing ACT.Global A/S provides disinfection and air purification solutions. Its product, Premium Purity, reduces the use of toxic chemicals, water, and plastic that are beneficial to sectors such as healthcare, hospitality, food processing, and beverages. The company was founded by Carsten Jensen in 2013 and is headquartered in Kastrup, Denmark. | Producer Manufacturing |
| Perfusion Tech ApS | |
Go-PEN Aps
Go-PEN Aps Medical SpecialtiesHealth Technology Go-Pen ApS develops insulin pen. The Danish company was founded in 2019 by Ole Kjerkegaard Nielsen, Michael Ejstrup Hansen. Ole Kjerkegaard Nielsen has been the CEO since 2019. | Health Technology |
| TXP Pharma GmbH |
- Borsa valori
- Insiders
- Jeppe Øvlesen
- Esperienza
